Major role for ACE-independent intrarenal ANG II formation in type II diabetes.
about
Direct evidence for intrarenal chymase-dependent angiotensin II formation on the diabetic renal microvasculature.Detailed localization of augmented angiotensinogen mRNA and protein in proximal tubule segments of diabetic kidneys in rats and humans.Nonclassical renin-angiotensin system and renal function.Chronic kidney disease prediction is an inexact science: The concept of "progressors" and "nonprogressors"The ins and outs of angiotensin processing within the kidney.Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17β-oestradiol-dependent and sex chromosome-independent.Network modeling reveals steps in angiotensin peptide processing.Intrarenal angiotensin-converting enzyme induces hypertension in response to angiotensin I infusionReciprocal changes in renal ACE/ANG II and ACE2/ANG 1-7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats.Glomerular filtration rate determinations in conscious type II diabetic mice.Intratubular renin-angiotensin system in hypertensionDiabetic Nephropathy Induced by Increased Ace Gene Dosage Is Associated with High Renal Levels of Angiotensin (1-7) and BradykininIncreased urinary excretion of angiotensinogen is associated with risk of chronic kidney diseaseMurine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2.Role of stimulated intrarenal angiotensinogen in hypertension.Urinary angiotensinogen as a novel early biomarker of intrarenal renin-angiotensin system activation in experimental type 1 diabetesDivergent localization of angiotensinogen mRNA and protein in proximal tubule segments of normal rat kidneyAugmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease.RAS-Mediated Adaptive Mechanisms in Cardiovascular Tissues: Confounding Factors of RAS Blockade Therapy and Alternative Approaches.Cardinal role of the intrarenal renin-angiotensin system in the pathogenesis of diabetic nephropathy.Enhanced vascular chymase-dependent conversion of endothelin in the diabetic kidney.Sex differences in angiotensin-converting enzyme modulation of Ang (1-7) levels in normotensive WKY ratsEvidence for a functional intracellular angiotensin system in the proximal tubule of the kidney.Oxidative stress/angiotensinogen/renin-angiotensin system axis in patients with diabetic nephropathyRegulation of urinary ACE2 in diabetic miceEstimation of angiotensin peptides in biological samples by LC/MS method.Insufficient hypothalamic angiotensin-converting enzyme 2 is associated with hypertension in SHR rats.Renoprotection and the Bardoxolone Methyl Story - Is This the Right Way Forward? A Novel View of Renoprotection in CKD Trials: A New Classification Scheme for Renoprotective Agents.Update on role of direct renin inhibitor in diabetic kidney disease.Efficiency and specificity of RAAS inhibitors in cardiovascular diseases: how to achieve better end-organ protection?Intrarenal renin angiotensin system revisited: role of megalin-dependent endocytosis along the proximal nephron.Unraveling the glomerular RAS: one peptidase at a time.Determination of sex differences in activities of angiotensin-converting enzyme 2 (ACE2) requires an activity assay that doesn't underestimate ACE2.Chymase: the other ACE?Elucidating mechanisms underlying altered renal autoregulation in diabetes.Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects.High glucose augments angiotensinogen in human renal proximal tubular cells through hepatocyte nuclear factor-5.Renal tubular ACE-mediated tubular injury is the major contributor to microalbuminuria in early diabetic nephropathy.Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling.Dietary sodium intake modulates renal excretory responses to intrarenal angiotensin (1-7) administration in anesthetized rats.
P2860
Q30533827-82197A55-FD12-461B-84B5-C07E4B1057F2Q33716378-6610A081-8059-4FFD-8E85-CB2BA2FA2D82Q34293723-1A92ACB6-30D5-456A-AF47-801E1434E7FCQ34367656-CC5D4532-F131-474F-ADAC-A8EE9FE24D68Q34428940-94B40C0A-6CDA-47F1-88AF-E3B6DD8956F4Q34439831-8E45B472-8BE4-43A1-A984-A8A0317F6F32Q34530891-A4E2F0FC-7DF8-4D54-BAFA-1714939E6020Q34695342-FD1BC8F2-344B-41C8-AEF6-EC2CA13CFA88Q34719150-CE91092A-36DE-437A-A15C-1166F614C716Q34719321-A9D9222B-F215-4050-BFB9-16EE2E9FCD99Q34777649-C53F45D7-16B6-4845-B444-9EE4DAEEB950Q36084248-9A0E0F15-D1B1-4486-B81B-DF2E0191421FQ36129853-DC8F906C-8D79-4028-9407-E23559F5F76CQ36185540-9DCB9F2F-C106-45B1-B852-02645564F53EQ36219052-3738260C-D6F9-46D4-B3BB-3646F5CF0984Q36236725-55EBC85E-516E-4B41-AD7F-716AADEBC84DQ36405827-20B40377-D411-4294-980A-EF14F9618A07Q36449123-9AA224E0-E71D-46AD-A40A-04A2D52A1ACDQ36551388-255F2C47-7180-4A04-A9C4-1CBD966503AEQ36561841-6AF4422C-0774-4498-BCBE-D20FEDC4172DQ36701565-511237E0-F28D-4D92-B297-9AB9D2AEC95EQ36853835-225F34E4-E2AB-49D9-ADDB-6788544D7170Q37324997-20F54CDA-CEE7-4652-94B0-E1DCC40DABA1Q37375567-29CC804A-4627-4757-9BFF-60257642E164Q37476622-30D8F12A-DB73-43C8-B57F-B539168D4A20Q37523322-773CD14B-F026-4148-8DE1-21A09B49D3C4Q37746299-C28F3FE3-6EBE-481A-9817-CDFDCF2BFDC5Q38107939-FE8A5B6F-420C-4513-9554-67E332B3AC33Q38200133-6904FD58-54DA-4C11-AF18-9B6A4189B3D2Q39416346-936A66AE-2E3E-4D52-9EC1-C2F1E76A81B2Q39641307-323E6C35-A1C3-434D-A392-B61CE096C02EQ42323090-661075A4-F2C0-42A8-A56F-8FA12F92C32FQ42357940-36615188-7CD1-4543-9982-1A6864F6D07AQ42937768-841A012F-1877-426E-AD4D-0217B5D4C4F0Q43900303-B1E8E353-BB23-4EFF-B276-E08EC9F84B31Q45276776-46CC2FEC-6DDF-459C-8AB2-38B81BD36DECQ47137843-E67E4BB2-DF59-431F-991D-5764E070C7EDQ47395588-60A1820B-8FB5-491B-B705-591314ADF967Q47652218-C369496E-BCBB-489E-9E3B-95067D2A4CB0Q48105741-0789D649-D5ED-44CF-B4E7-EA2448A6F36F
P2860
Major role for ACE-independent intrarenal ANG II formation in type II diabetes.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Major role for ACE-independent intrarenal ANG II formation in type II diabetes.
@ast
Major role for ACE-independent intrarenal ANG II formation in type II diabetes.
@en
Major role for ACE-independent intrarenal ANG II formation in type II diabetes.
@nl
type
label
Major role for ACE-independent intrarenal ANG II formation in type II diabetes.
@ast
Major role for ACE-independent intrarenal ANG II formation in type II diabetes.
@en
Major role for ACE-independent intrarenal ANG II formation in type II diabetes.
@nl
prefLabel
Major role for ACE-independent intrarenal ANG II formation in type II diabetes.
@ast
Major role for ACE-independent intrarenal ANG II formation in type II diabetes.
@en
Major role for ACE-independent intrarenal ANG II formation in type II diabetes.
@nl
P2093
P2860
P1476
Major role for ACE-independent intrarenal ANG II formation in type II diabetes.
@en
P2093
Benjamin J Bivona
Dale M Seth
Eric Lazartigues
Lisa M Harrison-Bernard
Mark C Chappell
Sungmi Park
P2860
P304
P356
10.1152/AJPRENAL.00519.2009
P577
2009-10-21T00:00:00Z